Vertex Pharmaceuticals Incorporated
IT ˙ BIT ˙ US92532F1003
366,30 € ↓ -1,30 (-0,35%)
2026-06-03
AKTIENPREIS
SecurityIT:1VRTX / Vertex Pharmaceuticals Incorporated
InstitutionEthic Inc.
Latest Disclosed Ownership17,896 shares
Latest Disclosed Value $ 7,991,429
Ethic Inc. reports 11.97% increase in ownership of 1VRTX / Vertex Pharmaceuticals Incorporated

On April 27, 2026 - Ethic Inc. filed a 13F-HR form disclosing ownership of 17,896 shares of Vertex Pharmaceuticals Incorporated (IT:1VRTX) valued at $6,793,322 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 3, 2026 disclosing 15,983 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of 11.97% during the quarter. The current value of the position is $6,555,305 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-27 2026-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 17,896 1,913 11.97 7,991 10.28 0.1217
2026-02-03 2025-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 15,983 2,012 14.40 7,246 32.44 0.1114
2025-10-17 2025-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 13,971 2,476 21.54 5,472 7.87 0.0900
2025-07-30 2025-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 11,495 58 0.51 5,073 -8.50 0.0909
2025-05-13 2025-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 11,437 -11,553 -50.25 5,544 -40.13 0.1123
2025-02-14 2024-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 22,990 3,197 16.15 9,258 11.91 0.1868
2024-11-13 2024-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 19,793 -1,369 -6.47 8,274 -16.59 0.2091
2024-08-13 2024-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 21,162 1,369 6.92 9,919 19.90 0.2326
2024-05-13 2024-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 19,793 2,157 12.23 8,274 15.30 0.2090
2024-02-14 2023-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 17,636 1,131 6.85 7,176 25.02 0.2123
2023-11-14 2023-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 16,505 1,769 12.00 5,739 10.68 0.2014
2023-08-14 2023-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 14,736 1,422 10.68 5,186 23.63 0.1923
2023-05-12 2023-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 13,314 4,611 52.98 4,195 66.89 0.1702
2023-02-14 2022-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 8,703 1,372 18.72 2,513 18.37 0.1358
2022-11-14 2022-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 7,331 1,326 22.08 2,123 25.47 0.1441
2022-08-10 2022-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 6,005 3,656 155.64 1,692 176.02 0.1179
2022-05-16 2022-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,349 157 7.16 613 27.44 0.0423
2022-02-14 2021-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,192 -1,894 -46.35 481 -35.09 0.0371
2021-11-15 2021-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 4,086 -124 -2.95 741 -12.72 0.0758
2021-08-10 2021-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 4,210 749 21.64 849 14.11 0.1029
2021-05-13 2021-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,461 966 38.72 744 26.10 0.1326
2021-02-10 2020-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,495 -104 -4.00 590 -16.55 0.1560
2020-10-27 2020-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,599 231 9.76 707 2.91 0.2704
2020-08-12 2020-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,368 1,420 149.79 687 203.98 0.3909
2020-05-15 2020-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 948 948 226 0.1887
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.